STIMEL-03® Frequently Asked Questions
These answers are general information for patients, caregivers, and healthcare professionals. They do not replace medical advice, device labeling, or instructions for use.
Understanding the Technology
What is STIMEL-03®?
STIMEL-03 is a neuromuscular rehabilitation system developed for clinician-guided therapy. It combines monitoring of muscle activity (EMG), electrical stimulation, and biofeedback to support rehabilitation exercises. Its use must follow the applicable product labeling and instructions for use.
What is functional electrical stimulation (FES)?
FES uses controlled electrical impulses to activate muscles during a functional task or movement. In rehabilitation, clinicians may use it as part of a broader program that includes task practice and other therapies.
What is the difference between FES and NMES?
Both approaches use electrical impulses to activate muscles. NMES is a broader term for neuromuscular stimulation, while FES generally describes stimulation coordinated with a functional activity, such as reaching or walking.
What is EMG biofeedback?
Electromyography (EMG) measures electrical activity produced by muscles. Biofeedback presents that activity to the patient or clinician, helping them observe attempted muscle activation during training.
How does EMG-triggered stimulation work?
The system monitors muscle activity during an attempted movement. When the measured signal meets a configured threshold, the system can deliver electrical stimulation to assist the exercise. Settings and treatment decisions are determined by the clinician.
How is EMG-triggered stimulation different from conventional stimulation?
In conventional stimulation, pulses may be delivered according to a programmed schedule. EMG-triggered stimulation links delivery to detected muscle activity during the patient's effort. Neither approach is universally preferable; the choice depends on clinical goals and the device's authorized use.
What does 'closed-loop' rehabilitation mean?
A closed-loop approach uses measured signals, such as muscle activity, to inform a system response. The exact feedback and adjustment functions depend on the specific device and software configuration.
Stroke Rehabilitation and Patient Suitability
Can STIMEL-03 be used in rehabilitation after stroke?
STIMEL-03 may be used in post-stroke rehabilitation according to its indications for use and the STIMEL-03 Operator's Manual. The patient's medical condition and the instructions in the manual determine suitability.
Can a person with little or no visible movement benefit from EMG-based training?
Some patients may produce detectable muscle activity even when movement is limited. A clinician can assess whether an EMG-based approach is technically feasible and clinically appropriate; benefit cannot be guaranteed.
Can STIMEL-03 restore movement after stroke?
STIMEL-03 is designed to support rehabilitation and may help patients regain movement in an arm affected by stroke. The extent of motor recovery is individual and varies from patient to patient; no specific outcome can be guaranteed.
Can STIMEL-03 help when the hand cannot open because of spasticity?
Yes. STIMEL-03 is intended to support treatment and rehabilitation in cases where the hand does not open, including cases involving spasticity, when consistent with its indications for use and Operator's Manual. Results vary by patient.
Is the system only for recent stroke survivors?
Suitability in earlier or later phases of rehabilitation must be evaluated individually. Treatment should be based on the device's authorized indications and the clinician's assessment rather than time since stroke alone.
When can rehabilitation with STIMEL-03 begin after a stroke?
Treatment may begin after the patient's medical condition has stabilized in the hospital. Depending on clinical suitability, the device instructions, and applicable requirements, treatment may start in a hospital, clinic, or at home.
Which parts of the body can be treated?
The body areas and muscle groups that may be treated depend on the specific STIMEL-03 configuration, approved indications, electrode setup, and clinician-selected protocol. Ask the clinical team for the current authorized applications.
Is the therapy suitable for every stroke survivor?
No. Some patients may have contraindications, precautions, or clinical needs that make a different approach more appropriate. A qualified healthcare professional must determine suitability.
Can it replace physiotherapy or occupational therapy?
No. Electrical stimulation and biofeedback are generally considered components of a comprehensive rehabilitation program, not substitutes for individualized clinical care.
Can treatment produce lasting improvements in movement?
Motion Informatics reports rehabilitation outcomes involving improvements in movement, range or angle of motion, and the position in space reached by the hand or leg, with improvements that may persist over time. The extent and durability of rehabilitation outcomes vary by patient.
Treatment Experience and Safety
What does a treatment session involve?
Follow the STIMEL-03 Operator's Manual and its integrated figures (FIGs) for the treatment procedure, electrode placement, settings, and operating steps. Treatment should be conducted in accordance with the device instructions and applicable clinical requirements.
Is electrical stimulation painful?
At the beginning of treatment, the operator identifies the stimulation level at which the muscles begin to move. An appropriate safety margin is then taken into account to minimize discomfort and avoid painful stimulation, in accordance with the STIMEL-03 Operator's Manual. Patients should report any pain immediately.
How long does each session last, and how many sessions are needed?
A typical treatment protocol lasts approximately 30–60 minutes. Longer sessions may lead to patient fatigue. The actual duration, frequency, and course of treatment should follow the STIMEL-03 Operator's Manual and the patient's condition.
Are there contraindications or precautions?
Yes. Electrical stimulation may be inappropriate or require special precautions for certain medical conditions or implanted devices. Patients must be screened according to the STIMEL-03 instructions for use. Do not rely on contraindication lists for other manufacturers' devices.
What if the skin becomes irritated under an electrode?
Stop the session and inform the treating clinician. Electrode condition, placement, and skin integrity should be assessed before treatment resumes, following the product instructions.
Can patients use STIMEL-03 at home?
STIMEL-03 is intended for use in hospitals, clinics, and independent home treatment by stroke survivors, subject to applicable product labeling and local laws. Sale for home use to a stroke survivor requires a prescription signed by a professional legally authorized to issue prescriptions in the relevant country. Users must follow the STIMEL-03 Operator's Manual.
Can STIMEL-03 be used with other rehabilitation treatments?
It may be considered within a multidisciplinary rehabilitation plan. The treating team should assess compatibility, treatment objectives, and safety before combining therapies.
Clinicians, Evidence and Practical Information
Can clinicians personalize stimulation settings?
STIMEL-03 treatment can be tailored to each patient's needs within the settings and procedures described in the STIMEL-03 Operator's Manual. The user must follow the manual when configuring and administering treatment.
How is progress monitored?
Clinicians may assess functional performance using standardized measures and, where supported, review session or EMG data. Device-generated metrics should complement rather than replace clinical assessment.
Is STIMEL-03 FDA cleared?
Motion Informatics describes STIMEL-03 as FDA-cleared. Customers should verify the specific model, indications, and applicable FDA 510(k) documentation before making regulatory or purchasing decisions. FDA clearance is not the same as FDA approval.
Is there clinical evidence supporting the technology?
Clinical studies have been conducted using STIMEL-03 devices. Published research on electrical stimulation, biofeedback, and post-stroke rehabilitation can also be found online.
How is STIMEL-03 different from NeuroMove NM900 or other FES systems?
STIMEL-03 is described by its developer as using highly sensitive detection of weak EMG signals associated with attempted movement after stroke, followed by noise reduction and amplification intended to preserve patient-specific signal characteristics. The company reports sensitivity at the picovolt level and describes this approach as supporting personalized rehabilitation.
Is the system available in my country?
Product availability and regulatory authorization vary by market. Contact Motion Informatics for the current status, authorized indications, and distribution options in your country.
Can I order if I don't live in Indiana or Florida?
Right now, STIMEL-03 is available only to customers in Indiana and Florida. If you live somewhere else, contact us and we'll reach out with next steps.
How can a hospital or rehabilitation center request a demonstration?
Use the 'Schedule a Demo' or contact options on motioninformatics.ai to request product information and discuss clinical needs with the company.
Who may operate STIMEL-03?
STIMEL-03 is designed to be operated by a person who has read, understood, and followed the STIMEL-03 Operator's Manual supplied with the device, subject to any applicable training, prescription, supervision, and local legal requirements.
Where can I obtain technical support or product documentation?
Contact Motion Informatics through its official website to request current instructions for use, training materials, software compatibility information, and authorized technical support.
Does insurance cover treatment with STIMEL-03?
Coverage depends on the country, insurer, clinical setting, medical necessity criteria, and billing rules. Motion Informatics cannot guarantee reimbursement; ask the treating provider and insurer for details.
Medical and regulatory notice. The information above is educational and does not constitute individual medical advice. Patient eligibility, contraindications, treatment protocols, and product availability must be confirmed using current product-specific instructions for use and applicable regulatory documentation. Individual results vary.